|
ATCC
human pancreatic ductal adenocarcinoma cell lines Human Pancreatic Ductal Adenocarcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sw+1990/pm41683204-47-0-15?v=ATCC Average 97 stars, based on 1 article reviews
human pancreatic ductal adenocarcinoma cell lines - by Bioz Stars,
2026-08
97/100 stars
|
Buy from Supplier |
|
ATCC
human pancreatic cancer cell lines sw1990 ![]() Human Pancreatic Cancer Cell Lines Sw1990, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/sw+1990/pmc08385122-306-0-6?v=ATCC Average 94 stars, based on 1 article reviews
human pancreatic cancer cell lines sw1990 - by Bioz Stars,
2026-08
94/100 stars
|
Buy from Supplier |
|
The SW 1990 line was established in 1978 from a spleen metastasis of a grade II pancreatic adenocarcinoma deriving from the exocrine pancreas.
The cells have a reported plating efficiency of 29%.
|
Buy from Supplier |
|
SW 1990 Cell Lines Complete Growth Medium is a cell lines complete growth medium from Innovative Research, supplied as a ready-to-use liquid. More Details: Formulation: Leibovitz's L-15 + 10% FBS + 1% P/S Bacterial detection:
|
Buy from Supplier |
Image Search Results
Journal: Molecular Therapy. Nucleic Acids
Article Title: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
doi: 10.1016/j.omtn.2021.06.005
Figure Lengend Snippet: Relative N6-methyladenine (m6A) RNA modification in total RNA is upregulated in pancreatic cancer (PC) (A and B) m6A content in total RNA in 16 pairs of pancreatic adenocarcinoma (PAAD) and corresponding para-tumor tissues. Except for patients 3 and 8, the relative m6A RNA modification of PAAD tissues was significantly higher than that of the corresponding para-tumor tissues. (C) Relative m6A RNA modification was higher in PC cell lines. Human PC cell lines (SW1990, AsPC-1, PANC-1, BxPC-3, and Capan-2) and a human immortalized pancreatic duct epithelial cell line (HPDE6-C7) were subjected to RNA m6A detection. Tumor, PAAD tissue. (B) ∗p < 0.05 by paired Student’s t test; (C) ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 by unpaired Student’s t test. Data are represented as mean ± standard error.
Article Snippet:
Techniques: RNA modification
Journal: Molecular Therapy. Nucleic Acids
Article Title: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
doi: 10.1016/j.omtn.2021.06.005
Figure Lengend Snippet: FTO acts as m6A demethylase in pancreatic cell lines (A and B) Quantitative real-time PCR and WB assays showed reduced FTO levels in five PC cell lines. The mRNA and protein levels of FTO were (C and E) significantly reduced in SW1990 cells after small interfering (si)RNAs (siFTO-1, siFTO-2, and siFTO-3) transfection, whereas were (D and F) significantly increased in BxPC-3 cells after transfection with wild-type FTO (FTO-WT) and mutant FTO (FTO-mut) overexpressing plasmids. (G) FTO knockdown significantly upregulated the m6A level in total RNA of SW1990 cells. (H) FTO-WT overexpression significantly decreased the m6A level in total RNA of BXPC-3 cells. No significant changes were observed in the m6A levels upon FTO-mut overexpression. GAPDH was used as internal control in the quantitative real-time PCR and WB assays. NC, negative control. (A–H) ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ns, no statistical significance by unpaired Student’s t test.
Article Snippet:
Techniques: Real-time Polymerase Chain Reaction, Transfection, Mutagenesis, Knockdown, Over Expression, Control, Negative Control
Journal: Molecular Therapy. Nucleic Acids
Article Title: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
doi: 10.1016/j.omtn.2021.06.005
Figure Lengend Snippet: FTO enhanced PJA2 stability in an m6A-YTHDF2-dependent manner in PC cells (A and B) Venn diagrams illustrated overlap in differentially bioinformatics analyses of the top 20 genes significantly positively or negatively related to FTO in PC. (C–F) Quantitative real-time PCR was performed to detect the mRNA expression of eight candidate genes after knockdown and overexpression of FTO in BxPC-3 and SW1990 cells. Only the PJA2 expression pattern, by both quantitative real-time PCR and WB, was consistent with that of FTO. (G) cBioPortal analysis displayed the co-expression relationship between FTO and PJA2 in PAAD tissues. Spearman coefficient: 0.74 (p = 2.10e−32); Pearson coefficient: 0.75 (p = 7.98e−34). (H and I) The relative PJA2 m6A level was detected in BxPC-3 and SW1990 cells after knockdown and overexpression of FTO, respectively. (J–M) Quantitative real-time PCR and WB were performed to detect the mRNA and protein expression of PJA2 after YTHDF1 and YTHDF2 knockdown by siRNA in BxPC-3 and SW1990 cells. (N and O) PJA2 stability was detected after knocking down YTHDF2, FTO by siRNA, and overexpression of FTO-WT and FTO-mut in BxPC-3 and SW1990 cells. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
Article Snippet:
Techniques: Real-time Polymerase Chain Reaction, Expressing, Knockdown, Over Expression